Capstone Investment Advisors’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-12,225
Closed -$352K – 1340
2024
Q4
$352K Sell
12,225
-4,479
-27% -$129K ﹤0.01% 1433
2024
Q3
$468K Buy
+16,704
New +$445K ﹤0.01% 1234
2024
Q2
– Sell
-32,630
Closed -$883K – 2054
2024
Q1
$883K Buy
+32,630
New +$927K ﹤0.01% 1223
2017
Q4
– Sell
-6,698
Closed -$340K – 489
2017
Q3
$340K Buy
+6,698
New +$358K 0.01% 376
2016
Q2
– Sell
-19,200
Closed -$656K – 675
2016
Q1
$656K Buy
+19,200
New +$758K 0.02% 371

Other funds holding ALKS

Capstone Investment Advisors's ALKS Position: Q1 2025 in Review

Capstone Investment Advisors sold out of Alkermes (ALKS) in Q1 2025, closing a stake of 12,225 shares — an estimated $352K sold.

Capstone Investment Advisors first reported a position in ALKS in Q1 2016 and held it in 5 quarters. The position peaked at $883K in Q1 2024. 371 funds tracked by Wall St. Rank hold ALKS as of Q1 2025.

  • Capstone Investment Advisors reported no remaining Alkermes position as of Q1 2025 after selling out during the quarter.
  • Capstone Investment Advisors sold 12,225 Alkermes shares in Q1 2025, an estimated $352K.
  • Capstone Investment Advisors first reported a position in Alkermes in Q1 2016 and held it in 5 quarters.
  • Capstone Investment Advisors's Alkermes position peaked at $883K in Q1 2024.
  • 371 funds tracked by Wall St. Rank held Alkermes as of Q1 2025.

Based on Capstone Investment Advisors's 13F filing for Q1 2025, filed 15 May 2025.